Image (1a2df8de F3dd 43d5 983b 28151463babc 01)
Chemical structure of Gabapentin, showing a cyclohexane ring with attached amine and carboxyl groups.*
Gabapentin Tablet
Product Images NDC 64380-727
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 64380-727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (1a2df8de F3dd 43d5 983b 28151463babc 02)
A line graph showing mean pain score over 8 weeks comparing placebo and Gabapentin 3600 mg/day. The x-axis represents weeks including a baseline, with a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows mean pain score from 0 to 10. Gabapentin group shows a decreasing trend in mean pain score, while placebo remains mostly steady.*
Figure 2 (1a2df8de F3dd 43d5 983b 28151463babc 03)
A line graph showing mean pain score over 7 weeks comparing Placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The timeline includes a 3-week dose titration period followed by a 4-week fixed dose period. Gabapentin groups show a greater reduction in mean pain score compared to placebo.*
Figure 3 (1a2df8de F3dd 43d5 983b 28151463babc 04)
A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo and gabapentin treatments in two studies. Study 1 shows 12% responders for placebo and 29% for gabapentin 3600 mg. Study 2 shows 14% responders for placebo, 32% for gabapentin 1800 mg, and 34% for gabapentin 2400 mg. Statistical significance is indicated with p-values less than 0.01 and 0.001.*
Figure 2 (1a2df8de F3dd 43d5 983b 28151463babc 05)
Scatter plot chart depicting percentage difference on the y-axis versus daily dose in mg on the x-axis for Gabapentin. Three studies (a, b, c) are represented with distinct symbols and colors, showing data points at various doses ranging from 600 to 1800 mg.*
600mg-100s (1a2df8de F3dd 43d5 983b 28151463babc 06)
Gabapentin Tablets, USP 600 mg oral tablets label by Strides Pharma Science Limited. The label indicates 100 tablets per bottle, prescription only, with dosage instructions and storage conditions. It includes manufacturer and distributor details, NDC 64380-727-01, and warnings to keep medication out of reach of children.*
800mg-100s (1a2df8de F3dd 43d5 983b 28151463babc 07)
Gabapentin Tablets, USP 800 mg oral tablets by Strides Pharma Science Limited. The label indicates a bottle containing 100 tablets for prescription use only. Instructions include storage conditions, child-resistant container, and pharmacist dispensing guidance. Manufacturer and distributor details are provided along with a barcode and lot number area.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
